Prenetics Global (PRE) Cash & Equivalents (2021 - 2025)

Prenetics Global (PRE) has 5 years of Cash & Equivalents data on file, last reported at $32.1 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $32.1 million, down 38.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.1 million (down 38.51% YoY), and the FY2025 annual result was $32.1 million, down 38.51% from the prior year.
• Cash & Equivalents grew to $32.1 million in Q4 2025 per PRE's latest filing, from $13.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $177.2 million in Q2 2023 and troughed at $13.3 million in Q3 2025.
• A 5-year average of $71.9 million and a median of $45.7 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 385.7% in 2023, then slumped 78.9% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $35.3 million in 2021, then jumped by 315.6% to $146.7 million in 2022, then sank by 68.84% to $45.7 million in 2023, then climbed by 14.32% to $52.3 million in 2024, then slumped by 38.51% to $32.1 million in 2025.
• Business Quant data shows PRE's Cash & Equivalents at $32.1 million in Q4 2025, $13.3 million in Q3 2025, and $17.2 million in Q2 2025.